{
    "2021-09-27": [
        [
            {
                "time": "",
                "original_text": "北向资金今日净买入14.77亿元，白酒股连续第二日遭疯抢",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净买入",
                        "白酒股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：确认政策底 行业迎来布局良机",
                "features": {
                    "keywords": [
                        "医药生物",
                        "政策底",
                        "布局良机"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：从景气度、竞争力、外需逻辑看诺禾致源投资价值",
                "features": {
                    "keywords": [
                        "医药生物",
                        "景气度",
                        "竞争力",
                        "外需逻辑",
                        "诺禾致源"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "健帆生物、南微医学、通策医疗、国际医学涨超6%，医疗ETF（159828）涨超2%",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "南微医学",
                        "通策医疗",
                        "国际医学",
                        "医疗ETF"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}